Plat

(redirected from Reteplase)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Related to Reteplase: Tenecteplase

Plat

A map of a town or a section of land that has been subdivided into lots showing the location and boundaries of individual parcels with the streets, alleys, easements, and rights of use over the land of another.

A plat is usually drawn to scale.

See: intertwine, land, plot

PLAT. A map of a piece of land, in which are marked the courses and distances of the different lines, and the quantity of land it contains.
     2. Such a plat;nay be given in evidence in ascertaining the position of the land, and what is included, and may serve to settle the figure of a survey, and correct mistakes. 5 Monr. 160. See 17 Mass. 211; 5 Greenl. 219; 7 Greenl, 61; 4 Wheat. 444; 14 Mass. 149.

References in periodicals archive ?
Keywords: Escherichia coli, Recombinant proteins, Reteplase, Tissue plasminogen activator
Plasmids were digested with Nco, and BamH, restriction enzymes to obtain reteplase cDNA inserts.
Connors suggested the lytic capabilities for intraarterial thrombolysis with reteplase and alteplase are about equal, and the optimal infusion concentrations should be about 1 U reteplase/100 cc normal saline infused at 0.
Reteplase has been used in thrombosed hemodialysis access grafts (Falk et al.
Reteplase is reconstituted only in sterile water for injection, USP (without preservatives) to achieve a final concentration of 1 U/1 ml and remains biologically active for at least 8 hours (Centocor, Inc.
But the value of adding reviparin or a similar agent remains in doubt when patients are treated with the fibrin-specific drugs typically used for thrombolysis in the United States, such as alteplase (tissue plasminogen activator), reteplase, and tenecteplase.
BRAVE was an open-label multicenter trial involving 253 German acute MI patients randomized to half-dose reteplase plus full-dose abciximab or to abciximab alone during the interval between diagnosis and transfer to a cardiac catheterization lab for PCI.
Published reports to date exclusively used streptokinase, urokinase, reteplase, or recombinant tissue plasminogen activator (t-PA).
All of these agents are given intravenously Alteplase (Activase), reteplase (Retavase), and tenecteplase (TNKase), produced with recombinant DNA technology are not teratogenic in animals and are all rated C.
Results of the Early Reteplase Thrombolysis in Myocardial Infarction-19 (ER TIMI-19) trial, reported by Dr.
One of the new options, half-dose reteplase plus heparin and a half dose of abciximab, an antiplatelet drug, looked especially good for younger patients and those with larger infarctions, Dr.